These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30169880)
1. Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics. Hench J; Bihl M; Bratic Hench I; Hoffmann P; Tolnay M; Bösch Al Jadooa N; Mariani L; Capper D; Frank S Neuro Oncol; 2018 Nov; 20(12):1682-1683. PubMed ID: 30169880 [No Abstract] [Full Text] [Related]
2. Neuro-oncology: Implications of the molecular era. Ruff MW; Uhm JH; Benarroch EE Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635 [TBL] [Abstract][Full Text] [Related]
3. Circulating biomarkers for high-grade glioma. Loo HK; Mathen P; Lee J; Camphausen K Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515 [No Abstract] [Full Text] [Related]
4. Biomarkers usher in era of personalized care for malignant glioma patients. Chakravarti A; Palanichamy K; Bell EH CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291 [No Abstract] [Full Text] [Related]
5. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma. Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997 [TBL] [Abstract][Full Text] [Related]
6. Blue Cross and Blue Shield Association's perspective on the common diagnostic testing guidelines. Tennenbaum D J Gen Intern Med; 1989; 4(6):553-4. PubMed ID: 2585165 [No Abstract] [Full Text] [Related]
7. Classifying Glioma via Liquid Biopsy: Progress toward an Unmet Clinical Need. Abdullah KG Clin Cancer Res; 2024 Jul; 30(14):2860-2861. PubMed ID: 38652677 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics]. Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141 [TBL] [Abstract][Full Text] [Related]
9. [Classification of gliomas. Current progress and perspectives]. Capper D; Reifenberger G Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737 [TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostics as a tool to personalize treatment in adult glioma patients. Jeuken JW; van der Maazen RW; Wesseling P Technol Cancer Res Treat; 2006 Jun; 5(3):215-29. PubMed ID: 16700618 [TBL] [Abstract][Full Text] [Related]
11. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Hochberg FH; Atai NA; Gonda D; Hughes MS; Mawejje B; Balaj L; Carter RS Expert Rev Mol Diagn; 2014 May; 14(4):439-52. PubMed ID: 24746164 [TBL] [Abstract][Full Text] [Related]
12. High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK. Jefferies SJ; Harris FP; Price SJ; Collins VP; Watts C Clin Oncol (R Coll Radiol); 2013 Jul; 25(7):391-3. PubMed ID: 23615180 [No Abstract] [Full Text] [Related]
13. Clinical practice guidelines for the management of adult diffuse gliomas. Jiang T; Nam DH; Ram Z; Poon WS; Wang J; Boldbaatar D; Mao Y; Ma W; Mao Q; You Y; Jiang C; Yang X; Kang C; Qiu X; Li W; Li S; Chen L; Li X; Liu Z; Wang W; Bai H; Yao Y; Li S; Wu A; Sai K; Li G; Yao K; Wei X; Liu X; Zhang Z; Dai Y; Lv S; Wang L; Lin Z; Dong J; Xu G; Ma X; Zhang W; Zhang C; Chen B; You G; Wang Y; Wang Y; Bao Z; Yang P; Fan X; Liu X; Zhao Z; Wang Z; Li Y; Wang Z; Li G; Fang S; Li L; Liu Y; Liu S; Shan X; Liu Y; Chai R; Hu H; Chen J; Yan W; Cai J; Wang H; Chen L; Yang Y; Wang Y; Han L; Wang Q; ; ; ; ; Cancer Lett; 2021 Feb; 499():60-72. PubMed ID: 33166616 [TBL] [Abstract][Full Text] [Related]
14. Value-based surgical pathology: a valuable concept. Fechner RE Am J Clin Pathol; 1997 Aug; 108(2):123-6. PubMed ID: 9260751 [No Abstract] [Full Text] [Related]
15. Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing. Lenting K; van den Heuvel CNAM; van Ewijk A; ElMelik D; de Boer R; Tindall E; Wei G; Kusters B; Te Dorsthorst M; Ter Laan M; Huynen MA; Leenders WP Acta Neuropathol Commun; 2019 Nov; 7(1):185. PubMed ID: 31747973 [TBL] [Abstract][Full Text] [Related]
17. Assessing what we do. The example of preoperative medical testing. Schein OD Arch Ophthalmol; 1996 Sep; 114(9):1129-31. PubMed ID: 8790102 [No Abstract] [Full Text] [Related]
18. Input of molecular analysis in medical management of primary brain tumor patients. Idbaih A; Duran-Peña A; Bonnet C; Ducray F Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669 [TBL] [Abstract][Full Text] [Related]
19. The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach. Villani V; Casini B; Tanzilli A; Lecce M; Rasile F; Telera S; Pace A; Piludu F; Terrenato I; Rollo F; De Nicola F; Fanciulli M; Pallocca M; Ciliberto G; Carosi M J Transl Med; 2023 Mar; 21(1):215. PubMed ID: 36959606 [TBL] [Abstract][Full Text] [Related]
20. Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. Parilla M; Kadri S; Patil SA; Fitzpatrick C; Ritterhouse L; Segal J; Collins J; Pytel P J Neuropathol Exp Neurol; 2019 Mar; 78(3):257-267. PubMed ID: 30698790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]